[1] YILDIRIM J G,ARABACI Z. Innovations in HPV vaccination and roles of nurses in cervical cancer prevention[J]. Asian Pac J Cancer Prev,2014,15(23):10053-10056. [2] NAKAGAWA J T,SCHIRMER J,BARBIERI M. Human papillomavirus(HPV) and uterine cervical cancer[J]. Rev Bras Enferm,2010,63(2):307-311. [3] STEBEN M,DUARTE-FRANCO E. Human papillomavirus infection:epidemiology and pathophysiology[J]. Gynecol Oncol, 2011,107(Sup 1):2-5. [4] VAN DER HEIJDEN E,LOPES A D,BRYANT A,et al. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ) for cervical intraepithelial neoplasia (CIN):Impact of human papillomavirus (HPV) test[J]. Cochrane Database Syst Rev,2015,1:CD010757. [5] NOWAKOWSKI A,DE-SOUZA S C,JACH R,et al. HPV-type distribution and reproducibility of histological diagnosis in cervical neoplasia in Poland[J]. Pathol Oncol Res,2015, 21(3):703-711. [6] LAI C Y,WU W W,TSAI S Y,et al. The effectiveness of a facebook-assisted teaching method on knowledge and attitudes about cervical cancer prevention and HPV vaccination intention among female adolescent students in Taiwan[J]. Health Educ Behav,2015,42(3):352-360. [7] GRCE M,MATOVINA M,MILUTIN-GASPEROV N,et al. Advances in cervical cancer control and future perspectives[J]. Coll Antropol,2010,34(2):731-736. [8] THABET M,HEMIDA R,HASAN M,et al. Human papillomavirus (HPV) is not the main cause of preinvasive and invasive cervical canceramong patients in Delta Region,Egypt[J]. J Exp Ther Oncol,2014,10(4):247-253. [9] DONGMEI W U,LIN CAI,MENG HUANG,et al. Prevalence of genital human papillomavirus infection and genotypes among women from Fujian province,PR China[J]. Eur J Obstet Gynecol Reprod Biol,2010,151(1):86. [10] LIU X,ZHANG S,RUAN Q,et al. Prevalence and type distribution of human papillomavirus in women with cervical lesions in Liaoning province,China[J]. Int J Gynecol Cancer, 2010,20(1):147. [11] 亚力坤·穆罕默德,玛依努尔·尼牙孜,韩莉莉,等. 中国妇产科临床杂志,2014,15(1):6-9. |